Form 4: Phreesia Director Edward Cahill Acquires Additional Shares Through Deferred Stock Units

Director Edward Cahill acquired 351 shares of Phreesia, Inc. common stock through deferred stock units, increasing his total holdings to 47,383 shares.

Summary

• On January 31, 2025, Edward L. Cahill, a director of Phreesia, Inc., acquired 351 shares of common stock.
• The acquisition was made through deferred stock units (DSUs) as part of the Non-Employee Director Deferred Compensation Program.
• The price per share was $28.46.
• Following the transaction, Cahill's total beneficial ownership of Phreesia common stock increased to 47,383 shares.
• The DSUs will be settled in common stock either 90 days after Cahill ceases to be a director or five years from the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating alignment of interests but without significant implications for the company's overall performance.

Positives

• Director's participation in the deferred compensation program demonstrates confidence in the company's future.
• Increased share ownership aligns director's interests with those of other shareholders.

Future Outlook

The director will receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of the Issuer and incurring a 'separation from service' within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (ii) five years from the date of grant of the DSUs.

Industry Context

Form 4 filings are routine disclosures of insider transactions and are common in the healthcare technology sector, reflecting standard compensation practices and alignment of interests between management and shareholders.

Comparison to Industry Standards

• Deferred stock units are a common form of compensation for directors in publicly traded companies, particularly in the tech and healthcare sectors.
• Companies like Teladoc Health and Veeva Systems also utilize similar equity-based compensation plans for their board members.
• The vesting terms of these DSUs (90 days post-service or 5 years from grant) are fairly standard compared to industry practices.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with theirs.
• The compensation structure could motivate the director to act in the best interests of the company.

Key Dates